retatrutide nejm 2023 obesity trial ly3437943 (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist— Obesity, NAFLD, and T2D Phase 2 Results Retatrutide Dosing Guide: 1-12 mg
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4



























